Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Mar;15(3):382–388. doi: 10.1016/j.bbmt.2008.12.494

Figure 1. Increased FOXP3 gene expression following CD4+ DLI plus low dose IL-2.

Figure 1

FOXP3 expression was assessed by real time PCR in PBMC from patients who received CD4+ DLI (black lines), low-dose IL-2 (blue lines) or combined CD4+ DLI and low-dose IL-2 (red lines). FOXP3 expression levels were normalized based on the expression of TFRC (transferrin receptor).